These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32580122)

  • 1. Identification of risk factors for hypertension and tachycardia upon dexmedetomidine discontinuation.
    Salah J; Grgurich P; Nault K; Lei Y
    J Crit Care; 2020 Oct; 59():81-85. PubMed ID: 32580122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of dexmedetomidine withdrawal in critically ill adults.
    Pathan S; Kaplan JB; Adamczyk K; Chiu SH; Shah CV
    J Crit Care; 2021 Apr; 62():19-24. PubMed ID: 33227592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discontinuation of prolonged infusions of dexmedetomidine in critically ill children with heart disease.
    Burbano NH; Otero AV; Berry DE; Orr RA; Munoz RA
    Intensive Care Med; 2012 Feb; 38(2):300-7. PubMed ID: 22160200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine as Single Continuous Sedative During Noninvasive Ventilation: Typical Usage, Hemodynamic Effects, and Withdrawal.
    Shutes BL; Gee SW; Sargel CL; Fink KA; Tobias JD
    Pediatr Crit Care Med; 2018 Apr; 19(4):287-297. PubMed ID: 29341985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential risk factors for dexmedetomidine withdrawal seizures in infants after surgery for congenital heart disease.
    Takahashi Y; Ueno K; Ninomiya Y; Eguchi T; Nomura Y; Kawano Y
    Brain Dev; 2016 Aug; 38(7):648-53. PubMed ID: 26908297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of dexmedetomidine therapy on the management of severe alcohol withdrawal syndrome in critically ill patients.
    Frazee EN; Personett HA; Leung JG; Nelson S; Dierkhising RA; Bauer PR
    J Crit Care; 2014 Apr; 29(2):298-302. PubMed ID: 24360597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged sedation in critically ill children: is dexmedetomidine a safe option for younger age? An off-label experience.
    Sperotto F; Mondardini MC; Vitale F; Daverio M; Campagnano E; Ferrero F; Rossetti E; Vasile B; Dusio MP; Ferrario S; Savron F; Brugnaro L; Amigoni A;
    Minerva Anestesiol; 2019 Feb; 85(2):164-172. PubMed ID: 30394067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged infusions of dexmedetomidine in critically ill patients.
    Guinter JR; Kristeller JL
    Am J Health Syst Pharm; 2010 Aug; 67(15):1246-53. PubMed ID: 20651314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Rebound Hypertension after Discontinuation of Dexmedetomidine.
    Flieller LA; Alaniz C; Pleva MR; Miller JT
    Pharmacotherapy; 2019 Oct; 39(10):970-974. PubMed ID: 31463963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of dexmedetomidine for sedation in critically ill mechanically ventilated pediatric burn patients.
    Lin H; Faraklas I; Sampson C; Saffle JR; Cochran A
    J Burn Care Res; 2011; 32(1):98-103. PubMed ID: 21088616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of prolonged dexmedetomidine use in critically ill children with heart disease*.
    Gupta P; Whiteside W; Sabati A; Tesoro TM; Gossett JM; Tobias JD; Roth SJ
    Pediatr Crit Care Med; 2012 Nov; 13(6):660-6. PubMed ID: 22791093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two cases of acute dexmedetomidine withdrawal syndrome following prolonged infusion in the intensive care unit: Report of cases and review of the literature.
    Kukoyi A; Coker S; Lewis L; Nierenberg D
    Hum Exp Toxicol; 2013 Jan; 32(1):107-10. PubMed ID: 23111887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.
    Riker RR; Shehabi Y; Bokesch PM; Ceraso D; Wisemandle W; Koura F; Whitten P; Margolis BD; Byrne DW; Ely EW; Rocha MG;
    JAMA; 2009 Feb; 301(5):489-99. PubMed ID: 19188334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonidine as a strategy for discontinuing dexmedetomidine sedation in critically ill patients: A narrative review.
    Glaess SS; Attridge RL; Christina Gutierrez G
    Am J Health Syst Pharm; 2020 Mar; 77(7):515-522. PubMed ID: 32086509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine Use in a Tertiary Care NICU: A Descriptive Study.
    Dersch-Mills DA; Banasch HL; Yusuf K; Howlett A
    Ann Pharmacother; 2019 May; 53(5):464-470. PubMed ID: 30501499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety and efficacy of dexmedetomidine-remifentanil in children undergoing flexible bronchoscopy: A retrospective dose-finding trial.
    Li X; Wang X; Jin S; Zhang D; Li Y
    Medicine (Baltimore); 2017 Mar; 96(11):e6383. PubMed ID: 28296782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term dexmedetomidine use and safety profile among critically ill children and neonates.
    Whalen LD; Di Gennaro JL; Irby GA; Yanay O; Zimmerman JJ
    Pediatr Crit Care Med; 2014 Oct; 15(8):706-14. PubMed ID: 25068249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose dexmedetomidine for sedation in the intensive care unit: an evaluation of clinical efficacy and safety.
    Jones GM; Murphy CV; Gerlach AT; Goodman EM; Pell LJ
    Ann Pharmacother; 2011 Jun; 45(6):740-7. PubMed ID: 21666095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weaning Dexmedetomidine in Non-ICU Areas: An Implementation Effort.
    Solodiuk JC; Sweet E; Greco C; Manzi SF; Giangregorio M; Homoki A; Li L; Mansfield L; Mahoney J; Kleinman ME
    Pediatr Crit Care Med; 2022 May; 23(5):353-360. PubMed ID: 34991138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hemodynamic effects of dexmedetomidine and esmolol in electroconvulsive therapy: a retrospective comparison.
    Aydogan MS; Yücel A; Begec Z; Colak YZ; Durmus M
    J ECT; 2013 Dec; 29(4):308-11. PubMed ID: 23774056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.